Fludarabine,Cyclophosphamide
not tagged
['lymphoma', 'lymsm']
congress|#eha2023 matthew frank discusses the safety and efficacy of cd22 cart therapy in pts with lbcl who have relapsed after cd19 cart therapy. the orr and cr rates were 68% and 53%, respectively #lymphoma #lymsm #medicalcongress 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm